GENE ONLINE|News &
Generic Drug Pricing Strategies & U.S. Prices Rise 300% in 10 Years
Generic drug manufacturers can employ various strategies to establish profitable and sustainable pricing, according to a recent analysis. These approaches include data-driven pricing models, strategic partnerships, and comprehensive market research. Understanding the nuances of the generic drug market and using them strategically can be beneficial, the analysis suggests. A study indicated that generic medication prices in the United States have risen by over 300% in the last ten years. This increase has surpassed inflation, impacting patients and payers. The analysis further suggests navigating the Hatch-Waxman Act, observing market trends, and conducting competitor analysis as effective strategies. More information is available at drugpatentwatch.com.
Newsflash | Powered by GeneOnline AI
Date: April 15, 2025
Author
LATEST
David vs. Goliath: Taiwan’s PGI Wins $23M Settlement in Sequencing Patent Dispute with U.S. PacBio
2026-03-13
Gut Microbiome Composition Predicts Long-term Cardiometabolic Health Outcomes in Diverse Urban Populations
2026-03-12
NVIDIA Ahead of GTC 2026: Markets Focus on Data Center Strength, PC Expansion, and the Next Technical Breakout
2026-03-12
Global and APAC Biopharma Watch: Capital Raising, Clinical Expansion, and Industry Moves in Focus
2026-03-12
EVENT
2026-04-09
4th Cell & Gene Therapy Innovation & Access Congress: Asia (Media Partnership)
Seoul, South Korea
2026-04-17
AACR Annual Meeting 2026 (Cancer Research & Early-Stage Breakthroughs)
San Diego, California
